Multi-Strategy Intervention for Anesthesia Care of Obese Patients A Factorial Randomized Controlled Trial
NCT05016076 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2022-05-24
Summary
The main objective of this study is to investigate the optimal anesthesia for obese patients undergoing bariatric surgery in the strategies of positive pulmonary ventilation, tracheal intubation technique, hemodynamic monitoring, and postoperative nausea and vomiting (PONV) prophylaxis, as the followed:
1. To evaluate the effectiveness and adverse effect of intravenous dexamethasone for PONV prophylaxis
2. To determine the safe inspiratory pressure to prevent the occurrence of gastric insufflation during facemask ventilation using point-of-care ultrasonography of antrum
3. To compare the effectiveness and safety between video intubating stylet and video laryngoscope in the placement of tracheal tubes
4. To apply minimally invasive CO monitors in guiding goal-directed hemodynamic therapy and assess its impact on major complications and postoperative recovery
Conditions
- Obesity
- Bariatric Surgery Candidate
- Tracheal Intubation Morbidity
- Nausea and Vomiting, Postoperative
- Hyperglycemia Drug Induced
- Gastric Reflux
Interventions
- DRUG
-
Dexamethasone 8 mg
In the designated patients, 8 mg of dexamethasone or placebo will be given intravenously within 10 minutes after the induction of anesthesia.
- DIAGNOSTIC_TEST
-
Applied inspiratory pressure (10, 15, 20, or 25 cmH2O)
A two-handed head-tilt jaw-thrust maneuver will be performed to establish an open airway. Once apnea determined by end-tidal capnography occurs, a mechanical ventilation with the assigned peak inspiratory pressure will be initiated. The pressure-controlled mode will be used with an inspiratory-to-expiratory ratio of 1:2 and no positive end-expiratory pressure (PEEP), at a frequency of 15 breath·min-1 and with 100% oxygen, by the ventilator (Carestation 620, Datex-Ohmeda, Inc., Madison, WI, USA).
- DEVICE
-
Tracheal intubation using video intubating stylet, video laryngoscopy, or direct laryngoscopy
In video intubating stylet group, a tracheal tube (ConvaTec, Berkshire, England, UK) in appropriate sizes is preloaded over the Trachway® video intubating stylet (TVI-4050, Markstein Sichtec Medical Corp, Taichung, Taiwan), which is introduced into oral cavity to visualize the epiglottis and guided to glottis via a monitor after full neuromuscular blockade is achieved. In video laryngoscopy group, a tracheal tube is preloaded over a GlideRite® stylet, which is specifically designed to work with GlideScope® video laryngoscope (Verathon Medical, Bothell, WA, USA). GlideScope® blade size 3 (GS-3) or 4 (GS-4) is used in all patients. In direct laryngoscopy group, tracheal tubes are prepared with a hockey stick-shaped stylet, and direct laryngoscopy is performed using a size-3 or -4 Macintosh blade (Rüsch Inc., Duluth, GA, USA).
- DEVICE
-
Goal-directed hemodynamic therapy targeting cardiac index
Subjects of the GDHT group will be managed according to the ERAS algorithm utilizing ProAQT® parameters to maintain the cardiac index ≥ 2.5 l·min-1·m-2. In brief, if cardiac index \< 2.5 l·min-1·m-2, a bolus of 150 ml of crystalloid fluid will be given until the stroke volume variation is \< 10%. If cardiac index \< 2.5 l·min-1·m-2 despite the stroke volume variation of ≥ 10% following fluid challenge, continuous intravenous infusion of dopamine 5-10 μg·kg-1·min-1 will be administered. If mean arterial pressure is \< 70 mmHg despite cardiac index ≥ 2.5 l·min-1·m-2, intravenous infusion of norepinephrine 2-10 μg·min-1 will be used.
- DRUG
-
Placebo (0.9% sodium chloride)
Placebo of 0.9% sodium chloride will be given intravenously within 10 minutes after the induction of anesthesia.
Sponsors & Collaborators
-
YingHsuanTai
lead OTHER
Principal Investigators
-
Ying-Hsuan Tai, M.D. · Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-31
- Primary Completion
- 2023-08-31
- Completion
- 2023-08-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Driving Pressure Guided Ventilation Versus Conventional Lung Protective Strategy in Morbid Obese Patients Undergoing Laparoscopic Bariatric Surgery
NCT04861168 ·Status: COMPLETED ·Phase: NA
-
Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery
NCT05286008 ·Status: UNKNOWN ·Phase: NA
-
Effects of Alveolar Recruitment Strategies on Arterial Oxygenation and Postoperative Inflammatory Response During Laparoscopic Bariatric Surgery: A Randomised Control Trial.
NCT05960071 ·Status: COMPLETED ·Phase: NA
-
Low-Flow Anesthesia and Perioperative Atelectasis in Laparoscopic Bariatric Surgery
NCT07041567 ·Status: COMPLETED ·Phase: NA
-
Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass Surgery
NCT01067209 ·Status: COMPLETED
-
Molecular, Metabolomic and Nutritional Changes After Metabolic Surgery
NCT05322551 ·Status: UNKNOWN
-
HFNC for Induction During Bariatric Surgery Patients.
NCT03155711 ·Status: COMPLETED ·Phase: NA
-
Comparing Analgesic Efficacy of Systemic Lidocaine Against Placebo in General Anesthesia in Bariatric Surgery
NCT03667001 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Significance of Alveolar Recruitment Maneuver During Bariatric Surgery
NCT02592226 ·Status: COMPLETED ·Phase: NA
-
Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery
NCT04501042 ·Status: UNKNOWN
-
Prospective Study to Determine Long Term Impact of Bariatric Surgery
NCT02813707 ·Status: UNKNOWN
-
Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19
NCT04486417 ·Status: UNKNOWN
-
Changes in Fat and Muscle Tissue Function and Their Impact on Metabolic Health After Bariatric Surgery
NCT07035483 ·Status: ACTIVE_NOT_RECRUITING
-
Preoperative Dexamethasone to Improve Quality of Recovery After Laparoscopic Bariatric Surgery
NCT05752734 ·Status: COMPLETED
-
Acute Effect of EPAP and Noninvasive Ventilation on Pulmonary Function and Lung Regional Ventilation on Bariatric Surgery
NCT02577744 ·Status: UNKNOWN ·Phase: NA
-
Study to Determine Incidence of Hypoventilation in Patients Who Have Undergone Gastric Bypass
NCT00316446 ·Status: COMPLETED
-
NPPV on Inflammatory Markers and Sleep in Severe Obese Patients With Metabolic Syndrome Undergone to Bariatric Surgery
NCT02409173 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Use of Noninvasive Ventilation in the Postoperative Period of Bariatric Surgery
NCT04805476 ·Status: COMPLETED ·Phase: NA
-
The Effect of Anesthetic Methods on Gastrointestinal Motility
NCT05951686 ·Status: COMPLETED ·Phase: NA
-
Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial
NCT05531474 ·Status: RECRUITING ·Phase: NA
-
Aminophylline on Perioperative Lung Mechanics in COPD Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery
NCT06125665 ·Status: RECRUITING ·Phase: NA
-
Assessment of Pulmonary Function in Relation to the Anesthetic Used in Patients Undergoing Bariatric Surgery
NCT06759623 ·Status: RECRUITING ·Phase: NA
-
Anesthesia for Obese Patients: Desflurane Versus Xenon
NCT01167803 ·Status: COMPLETED ·Phase: PHASE4
-
Opioid Free Anesthesia and Bariatric Surgery
NCT04144153 ·Status: COMPLETED ·Phase: PHASE4
-
Preoperative Nebulized Dexmedetomidine on Hemodynamic Changes in Laparoscopic Bariatric Surgery.
NCT06014359 ·Status: UNKNOWN ·Phase: NA